Results 181 to 190 of about 274,076 (393)
“G” NEUTROPENIA AND MULTIPLE IMMUNOLOGICAL DEFECTS [PDF]
J.A. Stockman+4 more
openalex +1 more source
O desenvolvimento de febre no doente com neutropenia induzida por quimioterapia mantém-se uma situação clinica muito desafiante na área oncológica. Apesar da evolução contínua na prevenção de infeção, a neutropenia febril mantém-se como uma complicação frequente em doentes oncológicos sob quimioterapia. Esta síndrome é considerada uma emergência médica
Atalaia, G, Vasconcelos, P, Bragança, N
openaire +1 more source
Abstract Targeted therapies and immune checkpoint inhibitors (ICIs) have significantly improved survival outcomes in metastatic renal cell carcinoma (mRCC) but are often associated with high rates of adverse events, leading to dose reductions or treatment discontinuation.
Zhiyuan Tan+4 more
wiley +1 more source
Prolonged antibiotic exposure causes dangerous hematologic side effects, including neutropenia, in up to 34% of patients. Murine studies established a link between the intestinal microbiota and hematopoiesis.
Josaura Fernandez‐Sanchez+12 more
doaj +1 more source
CHRONIC NEUTROPENIA WITH LEUKOAGGLUTININS AND B- AND T-CELL IMMUNODEFICIENCY [PDF]
Jeffrey I Schulman+2 more
openalex +1 more source
A case of idiosyncratic drug‐induced agranulocytosis because of sulbactam/ampicillin
We report a case of agranulocytosis caused by sulbactam/ampicillin. During antimicrobial therapy, close monitoring of total white blood cell counts is essential. Abstract Idiosyncratic drug‐induced agranulocytosis is a rare but life‐threatening condition that requires immediate medical intervention.
Kazuya Toda+4 more
wiley +1 more source
NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
La neutropenia febril es una condición frecuente en los pacientes pediátricos con cáncer. En el momento en que se hace este diagnóstico, el médico debe conducir una entrevista y un examen físico rigurosos, obtener cultivos e iniciar antibióticos para ...
Pio Lopez, Eduardo Lopez
doaj
Possible mechanism for mianserin induced neutropenia associated with saturable elimination kinetics. [PDF]
Jean O'Donnell+4 more
openalex +1 more source
ABSTRACT Background and Objectives Standard treatment of patients with stage II/III esophageal or gastroesophageal junction (E/GEJ) cancer involves neoadjuvant chemoradiation (nCRT), resection, and immunotherapy. Our trial evaluated the addition of perioperative avelumab to standard treatments.
Nataliya V. Uboha+15 more
wiley +1 more source